Jefferson Capital (JCAP) Asset Writedowns and Impairment (2024 - 2025)
Jefferson Capital's (JCAP) quarterly Asset Writedowns and Impairment came in at $690000.0 in Q4 2025, down 19.77% year-over-year from $860000.0 in Q4 2024, and up 21.27% quarter-over-quarter from $569000.0 in Q3 2025.
Powered by 
Analysis
Jefferson Capital (JCAP) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
Jefferson Capital (JCAP) has reported Asset Writedowns and Impairment for 2 consecutive years, with $690000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment fell 19.77% year-over-year to $690000.0 in Q4 2025; TTM through Dec 2025 was $3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.4 million, down 32.51% from the prior year.
- Asset Writedowns and Impairment was $690000.0 for Q4 2025 at Jefferson Capital, up from $569000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $867000.0 in Q3 2024 and troughed at $569000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn |
| 10 | Metalla Royalty & Streaming | 942.93 Mn | 931.86 Mn | 4.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 690,000.00 |
| Sep 30, 2025 | 569,000.00 |
| Dec 31, 2024 | 860,000.00 |
| Sep 30, 2024 | 867,000.00 |